MEDP — Medpace Holdings, Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1668397 ·
Last close
$653.09
Market Cap
$18.27B
52W High
$693.97
52W Low
$373.00
ADV30
282,815
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 716,000,000 | 223,885,000 | 165,540,000 | 137,460,000 | 2,302,595,000 | 705,315,000 | 1,717,656,000 |
| Jun 2026 | 707,331,000 | 201,637,000 | 146,824,000 | 121,362,000 | 2,057,181,000 | 502,688,000 | 1,623,320,000 |
| Mar 2026 | 706,604,000 | 196,326,000 | 141,503,000 | 123,870,000 | 2,129,613,000 | 652,681,000 | 1,531,299,000 |
| Dec 2025 | 708,450,000 | 205,316,000 | 153,269,000 | 135,133,000 | 1,975,472,000 | 497,049,000 | 1,516,401,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$752,660,000
Investing CF
$-45,766,000
Financing CF
$-249,528,000
CapEx
$-45,974,000
Dividends Paid
—
Buybacks
$-299,338,000
EPS Diluted TTM
$17.06
As of
2026-10-25
Balance + Analyst (yfinance extras)
Retained Earnings
$-511,368,000
Inventory
—
Receivables
$441,797,000
ST Investments
—
EBIT TTM
$583,404,000
Pretax Income TTM
$598,923,000
Interest Exp TTM
—
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,838,384,896
EBITDA
$634,462,976
Free Cash Flow
$497,776,000
Enterprise Value
$18,184,654,848
Total Cash
$705,315,008
Total Debt
$171,458,000
Shares Out
27,971,686
Trailing EPS
$18.01
Book Value
$20.92
ROE
117.9%
ROA
18.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,530,234,000 | 534,935,000 | 451,123,000 | 1,975,472,000 | 1,516,401,000 | 459,071,000 | 713,223,000 |
| Dec 2024 | 2,109,054,000 | 446,870,000 | 404,386,000 | 2,100,866,000 | 1,275,321,000 | 825,545,000 | 608,815,000 |
| Dec 2023 | 1,885,842,000 | 336,825,000 | 282,810,000 | 1,656,828,000 | 1,097,878,000 | 558,950,000 | 433,374,000 |
| Dec 2022 | 1,459,996,000 | 278,697,000 | 245,368,000 | 1,352,495,000 | 966,108,000 | 386,387,000 | 388,050,000 |
TTM Snapshot
Revenues TTM
$2,782,288,000
NetIncome TTM
$491,500,000
OpCashFlow TTM
—
Assets (Latest)
$2,057,181,000
Forward EPS
$19.85
Max Pain — expiry 2026-12-18
max pain strike: $570.00 · spot: $646.87 · call oi: 700 · put oi: 2,208Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $15.92B | $332.16 | — |
| ICLR | ICON PLC | $15.05B | $195.02 | — |
| INCY | INCYTE CORP | $24.27B | $119.09 | — |
| IQV | IQVIA HOLDINGS INC. | $42.45B | $257.60 | — |
| LNTH | Lantheus Holdings, Inc. | $6.66B | $101.80 | — |
News headlines (Yahoo Finance, 1h cache)
CON or MEDP: Which Is the Better Value Stock Right Now?
2026-11-18 15:40 · Yahoo
Are Options Traders Betting on a Big Move in Medpace Stock?
2026-11-16 12:57 · Yahoo
3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)
2026-11-11 16:45 · Yahoo
Did Earnings Beat Just Shift Medpace Holdings (MEDP) Investment Narrative?
2026-11-05 08:15 · Yahoo
CON vs. MEDP: Which Stock Is the Better Value Option?
2026-11-02 15:40 · Yahoo
Medpace (MEDP) is a Great Momentum Stock: Should You Buy?
2026-10-30 15:00 · Yahoo
Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?
2026-11-13 13:40 · Yahoo
ALC's Q3 Earnings Beat, Revenues Miss, '26 Outlook Narrows, Stock Down
2026-11-11 16:37 · Yahoo
TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances
2026-11-09 12:50 · Yahoo
Mettler-Toledo Stock Up on Q3 Earnings & Revenue Beat, '26 View Up
2026-11-06 13:08 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.